Dear Senator Shaheen and Senator Collins:
"On behalf of the Endocrine Society, thank you for introducing the Improving Needed Safeguards for users of Lifesaving Insulin Now (INSULIN) Act. The Endocrine Society is pleased to endorse this bipartisan legislation, which will take steps to lower the price of insulin, reduce out-of-pocket costs for patients, and limit formulary management barriers like prior authorization. The Endocrine Society is the world’s oldest and largest organization of scientists devoted to hormone research and physicians who care for people with hormone-related conditions like diabetes. While we hear from our members about many different clinical and research issues, the soaring price and out-of-pocket cost of insulin is the one causing greatest concern for our patients. This issue is of the utmost importance to our members, and we applaud you for your leadership to address this serious and life-threatening problem."
Read the Full Letter